adenylosuccinate synthetase 1 myopathy, ADSS1 myopathy, inborn error of metabolism, purine disorder, ultra-rare neuromuscular disease, skeletal muscle, cardiac muscle, clinical presentation, pre-clinical models, therapeutics, biomarkers, consortium, guidelines